“Effectiveness of Casirivimab-Imdevimab and Sotrovimab Monoclonal Antibody Treatment among High-Risk Patients with Sars-Cov-2 Infection: A Real-World Experience” (2023) Archives of Clinical and Biomedical Research, 7(3), pp. 325–336. Available at: https://fortunejournals.org/ojs/index.php/acbr/article/view/15015 (Accessed: 17 September 2026).